CD19阴性弥漫性大b细胞淋巴瘤表现为白血病期

IF 2.3 3区医学 Q3 MEDICAL LABORATORY TECHNOLOGY Cytometry Part B: Clinical Cytometry Pub Date : 2022-12-21 DOI:10.1002/cyto.b.22109

Thulasi Raman Ramalingam, Ragavi Uthayasuriyan, Vikram Prabhakar, Lakshman Vaidhyanathan

{"title":"CD19阴性弥漫性大b细胞淋巴瘤表现为白血病期","authors":"Thulasi Raman Ramalingam, Ragavi Uthayasuriyan, Vikram Prabhakar, Lakshman Vaidhyanathan","doi":"10.1002/cyto.b.22109","DOIUrl":null,"url":null,"abstract":"Diffuse large B cell lymphoma (DLBCL) is the most common non-Hodgkins lymphoma affecting elderly individuals. It is an aggressive disease, but the outcomes have quite improved after the addition of monoclonal antibodies to the chemotherapy regimen. DLBCL in leukemic phase (L-DLBCL) is extremely rare compared with other mature B cell neoplasms. L-DLBCL can mimic acute lymphoblastic leukemia and immunophenotyping (IPT)","PeriodicalId":10883,"journal":{"name":"Cytometry Part B: Clinical Cytometry","volume":"104 4","pages":"331-333"},"PeriodicalIF":2.3000,"publicationDate":"2022-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"CD19 negative diffuse large B-cell lymphoma presenting in leukemic phase\",\"authors\":\"Thulasi Raman Ramalingam, Ragavi Uthayasuriyan, Vikram Prabhakar, Lakshman Vaidhyanathan\",\"doi\":\"10.1002/cyto.b.22109\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Diffuse large B cell lymphoma (DLBCL) is the most common non-Hodgkins lymphoma affecting elderly individuals. It is an aggressive disease, but the outcomes have quite improved after the addition of monoclonal antibodies to the chemotherapy regimen. DLBCL in leukemic phase (L-DLBCL) is extremely rare compared with other mature B cell neoplasms. L-DLBCL can mimic acute lymphoblastic leukemia and immunophenotyping (IPT)\",\"PeriodicalId\":10883,\"journal\":{\"name\":\"Cytometry Part B: Clinical Cytometry\",\"volume\":\"104 4\",\"pages\":\"331-333\"},\"PeriodicalIF\":2.3000,\"publicationDate\":\"2022-12-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cytometry Part B: Clinical Cytometry\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/cyto.b.22109\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"MEDICAL LABORATORY TECHNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cytometry Part B: Clinical Cytometry","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cyto.b.22109","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}

引用次数: 1

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

CD19 negative diffuse large B-cell lymphoma presenting in leukemic phase

Diffuse large B cell lymphoma (DLBCL) is the most common non-Hodgkins lymphoma affecting elderly individuals. It is an aggressive disease, but the outcomes have quite improved after the addition of monoclonal antibodies to the chemotherapy regimen. DLBCL in leukemic phase (L-DLBCL) is extremely rare compared with other mature B cell neoplasms. L-DLBCL can mimic acute lymphoblastic leukemia and immunophenotyping (IPT)

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Cytometry Part B: Clinical Cytometry 医学-病理学

CiteScore

6.80

自引率

32.40%

发文量

审稿时长

>12 weeks

期刊介绍： Cytometry Part B: Clinical Cytometry features original research reports, in-depth reviews and special issues that directly relate to and palpably impact clinical flow, mass and image-based cytometry. These may include clinical and translational investigations important in the diagnostic, prognostic and therapeutic management of patients. Thus, we welcome research papers from various disciplines related [but not limited to] hematopathologists, hematologists, immunologists and cell biologists with clinically relevant and innovative studies investigating individual-cell analytics and/or separations. In addition to the types of papers indicated above, we also welcome Letters to the Editor, describing case reports or important medical or technical topics relevant to our readership without the length and depth of a full original report.